Concepedia

Mark J. Krantz

MJ

Statistics

Publications

31

Citations

2.4K

H-Index

24

Active since

1973

Affiliations

University of Alberta(Current)

Johns Hopkins University

Pratt Institute

Cancer Institute (WIA)

GDI Integrated Facility Services (Canada)

Mark J. Krantz is an author at University of Alberta specializing in life sciences, oncology, and biochemistry.

Publications per year

1973–2012

31

Publications

31

2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteins

Yuan Chuan Lee, Christopher P. Stowell, Mark J. Krantz · Biochemistry · 1976 · 333 citations

Life Sciences, Biochemistry, Chemical Biology +6

Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2

Babita Agrawal, Mark J. Krantz, Mark A. Reddish et al. · Nature Medicine · 1998 · 300 citations

Medicine, Cancer Biology, Oncology +10

Attachment of thioglycosides to proteins: enhancement of liver membrane binding

Mark J. Krantz, Neil A. Holtzman, Christopher P. Stowell et al. · Biochemistry · 1976 · 164 citations

Life Sciences, Biochemistry, Membrane Biochemistry +5

Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation.

Babita Agrawal, Mark J. Krantz, Joanne L. Parker et al. · PubMed · 1998 · 153 citations

Life Sciences, Cell Biology, Immunology +12

Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II‐defined cohort of patients with progressive multiple sclerosis: results of a 24‐month double‐blind placebo‐controlled clinical trial and 5 years of follow‐up treatment

Kenneth G. Warren, Ingrid Catz, L. Z. Ferenczi et al. · European Journal of Neurology · 2006 · 147 citations

Life Sciences, Immunology, Neurology +17

1–5 of 31